> Complete tumor regression was observed in 6/15 mice on the combination treatment, 1/20 on ivermectin alone, 1/10 on anti-PD1 antibody alone, and 0/25 on no treatment.
As I mentioned above (another comment), pharma tends to avoid developing applications for generic/cheap drugs so we may not see more research on this front. Who knows.
If there is a x5 improvement they will get a method to package both drugs together and sell them for x10 the price. You surely want a profesional mix in the high tech lab instead of a random guy mixing tubes in the back room. Another trick is to add something to the molecule like a methyl -CH3, show that the new version is 10% even better and charge x20 for it.
So my guess is that there is some problem to use this mix, but as I said I can't find any obvious error and it's really interesting. I'd love to read a better analysis from someone that is an expert in the area.
I tried with 17: https://pmc.ncbi.nlm.nih.gov/articles/PMC7925581/
From figure 1:
> Complete tumor regression was observed in 6/15 mice on the combination treatment, 1/20 on ivermectin alone, 1/10 on anti-PD1 antibody alone, and 0/25 on no treatment.
Ok, that looks interesting.
Right? I learned too.
As I mentioned above (another comment), pharma tends to avoid developing applications for generic/cheap drugs so we may not see more research on this front. Who knows.
Big Pharma is more greedy than evil.
If there is a x5 improvement they will get a method to package both drugs together and sell them for x10 the price. You surely want a profesional mix in the high tech lab instead of a random guy mixing tubes in the back room. Another trick is to add something to the molecule like a methyl -CH3, show that the new version is 10% even better and charge x20 for it.
So my guess is that there is some problem to use this mix, but as I said I can't find any obvious error and it's really interesting. I'd love to read a better analysis from someone that is an expert in the area.